These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1238 related items for PubMed ID: 23553454

  • 1. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Sep; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 3. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [Abstract] [Full Text] [Related]

  • 5. Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
    Anggorowati N, Yano Y, Heriyanto DS, Rinonce HT, Utsumi T, Mulya DP, Subronto YW, Hayashi Y.
    J Med Virol; 2012 Jun; 84(6):857-65. PubMed ID: 22499006
    [Abstract] [Full Text] [Related]

  • 6. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS, Singh NB, Singh HL, Singh YM.
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW, Agyei AA, Ziga F, Lartey M, Adiku TK, Seshi M, Arens MQ, Mingle JA.
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [Abstract] [Full Text] [Related]

  • 8. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S, Singh S.
    BMC Infect Dis; 2010 Mar 07; 10():53. PubMed ID: 20205948
    [Abstract] [Full Text] [Related]

  • 9. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 07; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 10. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR, Gui X, Chen XY, Zhu Y.
    J Med Virol; 2011 Jul 07; 83(7):1159-64. PubMed ID: 21567419
    [Abstract] [Full Text] [Related]

  • 11. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.
    HIV Med; 2010 Jan 07; 11(1):85-9. PubMed ID: 19659944
    [Abstract] [Full Text] [Related]

  • 12. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF, Liu L, Zheng YF, Shen YZ, Chen J, Gu SM, Wang JR, Lu HZ.
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar 07; 21(3):189-91. PubMed ID: 23967739
    [Abstract] [Full Text] [Related]

  • 13. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R, Peng J, Tang L, Huang H, Liu M, Kong W, Pang B.
    J Med Virol; 2013 Oct 07; 85(10):1712-23. PubMed ID: 23868809
    [Abstract] [Full Text] [Related]

  • 14. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar 07; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection.
    Firnhaber C, Chen CY, Evans D, Maskew M, Schulz D, Reyneke A, Kramvis A.
    Int J Infect Dis; 2012 Apr 07; 16(4):e268-72. PubMed ID: 22305987
    [Abstract] [Full Text] [Related]

  • 18. Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
    Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi AA, McFarland W, Eslamifar A, Ramezani A.
    J Addict Med; 2012 Dec 07; 6(4):292-6. PubMed ID: 22895463
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN.
    J Health Popul Nutr; 2000 Dec 07; 18(3):145-50. PubMed ID: 11262767
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran.
    SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, Jabbari H, Mohraz M.
    Acta Med Iran; 2011 Dec 07; 49(4):252-7. PubMed ID: 21713737
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 62.